viernes, 27 de octubre de 2023

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers Damian McNamara, MA

https://www.medscape.com/viewarticle/997718

No hay comentarios:

Publicar un comentario